Stay updated on PD-1 Inhibitor Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the PD-1 Inhibitor Combo in NSCLC Clinical Trial page.
Latest updates to the PD-1 Inhibitor Combo in NSCLC Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 on the page, with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer.SummaryDifference0.1%
- Check54 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 in the page header.SummaryDifference0.0%
- Check61 days agoChange DetectedRemoved the site-wide government funding status notice from the page; no study content or data were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check76 days agoChange DetectedNo significant differences in the core content of the Study Details page between the two screenshots; the study title, status, enrollment, and locations appear the same, with any differences likely cosmetic. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check104 days agoChange Detected- Added a government-operational-status notice and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%
Stay in the know with updates to PD-1 Inhibitor Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibitor Combo in NSCLC Clinical Trial page.